Archive for 2003

San DNAgo

San DNAgo Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.

Puncturing The ImClone Hype

Puncturing The ImClone Hype Could ImClone Systems’ Erbitux be a powerful cancer fighter after all? Maybe. A new study presented June 1 at a meeting of oncologists seems to boost that contention. But there are still reasons to doubt that Erbitux will be approved soon or that it will eventually be a blockbuster.

Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!